Evidence map›Paper›PMID 34400840›Full record

ReviewNature protocols2021

High spatial and temporal resolution Ca

Lyudmyla Borysova, Y Y Hanson Ng, Edward S Wragg, Lillian E Wallis, Emily Fay, Raimondo Ascione, Kim A Dora

Open access · greenAbstract readReview
PubMed Publisher
In one paragraph

Review in Nature protocols, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Lyudmyla BorysovaVascular Pharmacology Group, Department of Pharmacology, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0003-0458-9871
Y Y Hanson NgVascular Pharmacology Group, Department of Pharmacology, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0003-3260-424X
Edward S WraggVascular Pharmacology Group, Department of Pharmacology, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-5489-0526
Lillian E WallisVascular Pharmacology Group, Department of Pharmacology, University of Oxford, Oxford, UK.
Emily FayVascular Pharmacology Group, Department of Pharmacology, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-0133-8420
Raimondo AscioneBristol Heart Institute, Bristol Royal Infirmary, University of Bristol, Bristol, UK.ORCID http://orcid.org/0000-0001-8045-5619
Kim A DoraVascular Pharmacology Group, Department of Pharmacology, University of Oxford, Oxford, UK. kim.dora@pharm.ox.ac.uk.ORCID http://orcid.org/0000-0002-8014-2775
University of Oxford · GBBristol Royal Infirmary · GB

Funding

British Heart Foundation FS/08/033/25111British Heart Foundation FS/13/16/30199British Heart Foundation PG/14/58/30998British Heart Foundation PG/16/104/32652British Heart Foundation PG/18/11/33552British Heart Foundation PG/18/49/33833British Heart Foundation RE/13/1/30181Medical Research Council MR/L012723/1
6 · The paper itself

Abstract

Ca

Indexed as

CalciumMyocytes, CardiacAnimalsCalcium SignalingHumansMyocardial ContractionMyocardiumRatsSwineCalcium

Identifiers

PMID34400840
OpenAlexW3186438061

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.